• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞及 FoxP3 基因表达在衰老过程中的变化及其与人类和小鼠肺部肿瘤的关系。

Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.

机构信息

Special Requirement Ward, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.

出版信息

Chin Med J (Engl). 2012 Jun;125(11):2004-11.

PMID:22884069
Abstract

BACKGROUND

Immunosuppressive regulatory T cells (Tregs) participate in tumor immune evasion and the number and suppressive function of Tregs change with the aging process, but it is not clear whether such change leads to a higher incidence of tumors in the elderly. To this end, we designed experiments to explore the changes of Tregs and the functional gene Forkhead box P3 (FoxP3) in the aging process and its relationship with lung tumors in humans and mice.

METHODS

The percentage of CD4(+)CD25(+)CD127(low) Tregs and expression of FoxP3 mRNA were analyzed using flow cytometry (FCM) and real-time fluorescence-based quantitative polymerase chain reaction (FQ-PCR). Markers were analyzed in the peripheral blood (PB) of 65 elderly patients (age ≥ 65 years) with primary non-small cell lung cancer (NSCLC), 20 younger patients (aged < 55 years) with NSCLC, 30 elderly healthy individuals and 30 young healthy individuals. Furthermore, we set up the Lewis lung cancer model with C57BL/6 female mice. Thirty-six mice were divided into a young healthy group, a middle-aged healthy group, an elderly healthy group, a young tumor group, a middle-aged tumor group, and an elderly tumor group. The percentage of CD4(+)CD25(+)FoxP3(+) Tregs and the expression level of FoxP3 mRNA in splenocytes were determined in the six groups.

RESULTS

The percentage of peripheral CD4(+)CD25(+)CD127(low) Tregs and the expression of FoxP3 mRNA were significantly increased in elderly patients with NSCLC comparing with the other groups and in elderly healthy individuals compared with young healthy individuals. Further analysis showed that the percentage of CD4(+)CD25(+)CD127(low) Tregs and the expression of FoxP3 mRNA were closely associated with tumor node metastasis (TNM) staging in elderly patients with NSCLC. In the mouse model, the percentage of CD4(+)CD25(+)FoxP3(+) Tregs and the expression of FoxP3 mRNA in splenocytes of the tumor groups were significantly higher than in the healthy groups, with the highest expression in the elderly tumor group. In the healthy groups, the elderly healthy mice had the highest percentage of Tregs and expression of FoxP3 mRNA. The elderly mice had larger and heavier tumors than did the young and middle aged mice.

CONCLUSIONS

The up-regulation of Tregs and the FoxP3 gene with aging may play an essential role in oncogenesis and development of lung tumors in an elderly population.

摘要

背景

免疫抑制调节性 T 细胞(Tregs)参与肿瘤免疫逃逸,Tregs 的数量和抑制功能随衰老过程而变化,但尚不清楚这种变化是否会导致老年人肿瘤发病率升高。为此,我们设计实验探讨 Tregs 及其功能基因叉头框 P3(FoxP3)在衰老过程中的变化及其与人类和小鼠肺部肿瘤的关系。

方法

采用流式细胞术(FCM)和实时荧光定量聚合酶链反应(FQ-PCR)分析 CD4(+)CD25(+)CD127(low)Tregs 的百分比和 FoxP3 mRNA 的表达。分析了 65 例老年原发性非小细胞肺癌(NSCLC)患者(年龄≥65 岁)、20 例年轻 NSCLC 患者(年龄<55 岁)、30 例老年健康人和 30 例年轻健康人的外周血(PB)标志物。此外,我们建立了 C57BL/6 雌性小鼠的 Lewis 肺癌模型。36 只小鼠分为年轻健康组、中年健康组、老年健康组、年轻肿瘤组、中年肿瘤组和老年肿瘤组。检测六组脾细胞 CD4(+)CD25(+)FoxP3(+)Tregs 的百分比和 FoxP3mRNA 的表达水平。

结果

与其他组相比,老年 NSCLC 患者外周血 CD4(+)CD25(+)CD127(low)Tregs 的百分比和 FoxP3mRNA 的表达明显升高,与年轻健康者相比,老年健康者也明显升高。进一步分析表明,老年 NSCLC 患者外周血 CD4(+)CD25(+)CD127(low)Tregs 的百分比和 FoxP3mRNA 的表达与 TNM 分期密切相关。在小鼠模型中,肿瘤组脾细胞 CD4(+)CD25(+)FoxP3(+)Tregs 的百分比和 FoxP3mRNA 的表达明显高于健康组,其中老年肿瘤组最高。在健康组中,老年健康小鼠的 Tregs 比例和 FoxP3mRNA 的表达最高。老年小鼠的肿瘤比年轻和中年小鼠更大、更重。

结论

随着年龄的增长,Tregs 和 FoxP3 基因的上调可能在老年人群肺癌的发生和发展中发挥重要作用。

相似文献

1
Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.调节性 T 细胞及 FoxP3 基因表达在衰老过程中的变化及其与人类和小鼠肺部肿瘤的关系。
Chin Med J (Engl). 2012 Jun;125(11):2004-11.
2
No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.1型糖尿病中FOXP3 +调节性T细胞频率无改变。
Diabetes. 2007 Mar;56(3):604-12. doi: 10.2337/db06-1248.
3
Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.用条件培养基转化的调节性 T 细胞抑制小鼠同种异体免疫。
J Surg Res. 2011 Dec;171(2):797-806. doi: 10.1016/j.jss.2010.03.044. Epub 2010 Apr 15.
4
CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.雷帕霉素将外周血 CD4+CD25(-) 初始 T 细胞体外诱导为 CD4+Foxp3+ 调节性 T 细胞后其体外调节能力增强。
Chin Med J (Engl). 2010 Apr 5;123(7):942-8.
5
CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.CD4(+)CD25(+)CD127(low/-)调节性T细胞表达Foxp3并抑制效应T细胞增殖,促进胃癌进展。
Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.
6
Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.高效抗逆转录病毒治疗(HAART)下HIV-1感染者CD4+CD25+调节性T细胞中免疫激活程度、白细胞介素-2产生与叉头框蛋白P3(FOXP3)表达之间的相关性
Int Immunopharmacol. 2009 Jul;9(7-8):831-6. doi: 10.1016/j.intimp.2009.03.009. Epub 2009 Mar 18.
7
Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.自身免疫性甲状腺疾病患儿 CD4+CD25(high) 和 CD4+FoxP3 的比例较低,但 CD4+CD25+CD127(low)FoxP3+T 细胞水平没有变化。
Autoimmunity. 2013 May;46(3):222-30. doi: 10.3109/08916934.2012.751981. Epub 2013 Jan 22.
8
Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.尼古丁刺激 α7 烟碱型乙酰胆碱受体可增加体外培养的小鼠天然存在的 CD4+CD25+调节性 T 细胞的抑制能力。
J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.
9
Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.常见可变免疫缺陷患者中 CD4(+) CD25(+) FOXP3(+) 调节性 T 细胞抑制性标记物的频率和表达。
Scand J Immunol. 2013 May;77(5):405-12. doi: 10.1111/sji.12040.
10
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.继发于产生干扰素-α的抗原呈递细胞的未经治疗的活动性系统性红斑狼疮中功能失调的CD4 +、CD25 +调节性T细胞。
Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.

引用本文的文献

1
Immunosenescence promotes cancer development: from mechanisms to treatment strategies.免疫衰老促进癌症发展:从机制到治疗策略。
Cell Commun Signal. 2025 Mar 10;23(1):128. doi: 10.1186/s12964-025-02082-6.
2
Immunosenescence, Physical Exercise, and their Implications in Tumor Immunity and Immunotherapy.免疫衰老、体育锻炼及其对肿瘤免疫和免疫治疗的影响。
Int J Biol Sci. 2025 Jan 6;21(3):910-939. doi: 10.7150/ijbs.100948. eCollection 2025.
3
Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated -mutated advanced non-small cell lung cancer: a prospective observational study.
肿瘤程序性死亡配体-1表达对未经治疗的EGFR突变型晚期非小细胞肺癌中奥希替尼疗效的影响:一项前瞻性观察研究。
Transl Lung Cancer Res. 2021 Aug;10(8):3582-3593. doi: 10.21037/tlcr-21-461.
4
Immunosenescence: a key player in cancer development.免疫衰老:癌症发展中的关键因素。
J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z.
5
Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.多西他赛联合雷莫西尤单抗治疗既往治疗过的非小细胞肺癌患者的回顾性分析。
Transl Lung Cancer Res. 2019 Aug;8(4):450-460. doi: 10.21037/tlcr.2019.08.07.
6
PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis.程序性死亡受体配体1(PD-L1)表达与软组织肉瘤中叉头框蛋白P3(FOXP3)+调节性T细胞浸润及患者预后不良相关。
J Cancer. 2017 Jul 5;8(11):2018-2025. doi: 10.7150/jca.18683. eCollection 2017.
7
Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.未治疗的非小细胞肺癌患者循环调节性 T 细胞亚群的预后价值。
Sci Rep. 2016 Dec 15;6:39247. doi: 10.1038/srep39247.
8
Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma.伊朗南部肺癌患者中FOXP3基因-2383 C/T和IVS9+459 T/C位点的遗传变异研究。
Iran J Basic Med Sci. 2015 May;18(5):465-71.
9
Optimization of immunotherapy in elderly cancer patients.老年癌症患者免疫治疗的优化
Crit Rev Oncog. 2013;18(6):573-83. doi: 10.1615/critrevoncog.2013010591.
10
Age-related autoimmunity.与年龄相关的自身免疫。
BMC Med. 2013 Apr 4;11:94. doi: 10.1186/1741-7015-11-94.